GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Current Ratio

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Current Ratio : 8.03 (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Cryofocus Medtech (Shanghai) Co's current ratio for the quarter that ended in Jun. 2023 was 8.03.

Cryofocus Medtech (Shanghai) Co has a current ratio of 8.03. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's Current Ratio or its related term are showing as below:

HKSE:06922' s Current Ratio Range Over the Past 10 Years
Min: 2.17   Med: 6.24   Max: 8.03
Current: 4.87

During the past 4 years, Cryofocus Medtech (Shanghai) Co's highest Current Ratio was 8.03. The lowest was 2.17. And the median was 6.24.

HKSE:06922's Current Ratio is ranked better than
72.63% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: 2.715 vs HKSE:06922: 4.87

Cryofocus Medtech (Shanghai) Co Current Ratio Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Current Ratio Chart

Cryofocus Medtech (Shanghai) Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Current Ratio
2.17 6.69 5.78 4.87

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Current Ratio Get a 7-Day Free Trial 6.69 - 5.78 8.03 4.87

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Current Ratio

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryofocus Medtech (Shanghai) Co's Current Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Current Ratio distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Current Ratio falls into.



Cryofocus Medtech (Shanghai) Co Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Cryofocus Medtech (Shanghai) Co's Current Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Current Ratio (A: Dec. 2022 )=Total Current Assets (A: Dec. 2022 )/Total Current Liabilities (A: Dec. 2022 )
=295.045/51.072
=5.78

Cryofocus Medtech (Shanghai) Co's Current Ratio for the quarter that ended in Jun. 2023 is calculated as

Current Ratio (Q: Jun. 2023 )=Total Current Assets (Q: Jun. 2023 )/Total Current Liabilities (Q: Jun. 2023 )
=228.942/28.519
=8.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cryofocus Medtech (Shanghai) Co  (HKSE:06922) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Cryofocus Medtech (Shanghai) Co Current Ratio Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Traded in Other Exchanges
N/A
Address
Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines